PT3574901T - Dispositivos de injecção compreendendo uma composição de ácido hialurónico e cloridrato de mepivacaína - Google Patents

Dispositivos de injecção compreendendo uma composição de ácido hialurónico e cloridrato de mepivacaína

Info

Publication number: PT3574901T
Authority: PT; Portugal
Prior art keywords: composition; hyaluronic acid; injection devices; mepivacaine hydrochloride; mepivacaine
Prior art date: 2013-07-30

Application number

PT191802982T

Other languages

English (en)

Original Assignee

Teoxane

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-07-30

Filing date

2014-07-29

Publication date

2022-04-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51570796&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3574901(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-07-29 Application filed by Teoxane filed Critical Teoxane

2022-04-08 Publication of PT3574901T publication Critical patent/PT3574901T/pt

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
238000002347 injection Methods 0.000 title 1
239000007924 injection Substances 0.000 title 1
229960002660 mepivacaine hydrochloride Drugs 0.000 title 1
RETIMRUQNCDCQB-UHFFFAOYSA-N mepivacaine hydrochloride Chemical compound Cl.CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C RETIMRUQNCDCQB-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Birds (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Inorganic Chemistry (AREA)
Gerontology & Geriatric Medicine (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Anesthesiology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PT191802982T 2013-07-30 2014-07-29 Dispositivos de injecção compreendendo uma composição de ácido hialurónico e cloridrato de mepivacaína PT3574901T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13/954,360 US9421198B2 (en)	2013-07-30	2013-07-30	Composition comprising hyaluronic acid and mepivacaine

Publications (1)

Publication Number	Publication Date
PT3574901T true PT3574901T (pt)	2022-04-08

Family

ID=51570796

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT14767131T PT3027186T (pt)	2013-07-30	2014-07-29	Processo para a preparação de composições compreendendo ácido hialurónico e cloridrato de mepivacaína
PT191802982T PT3574901T (pt)	2013-07-30	2014-07-29	Dispositivos de injecção compreendendo uma composição de ácido hialurónico e cloridrato de mepivacaína

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT14767131T PT3027186T (pt)	2013-07-30	2014-07-29	Processo para a preparação de composições compreendendo ácido hialurónico e cloridrato de mepivacaína

Country Status (20)

Country	Link
US (9)	US9421198B2 (pt)
EP (2)	EP3574901B1 (pt)
JP (1)	JP6543625B2 (pt)
KR (2)	KR20210110406A (pt)
CN (2)	CN105682657A (pt)
AU (1)	AU2014298046B2 (pt)
BR (1)	BR112016002171A2 (pt)
CA (1)	CA2919792C (pt)
CY (1)	CY1122648T1 (pt)
DK (2)	DK3574901T3 (pt)
ES (2)	ES2743755T3 (pt)
HR (1)	HRP20191345T1 (pt)
HU (1)	HUE045969T2 (pt)
LT (1)	LT3027186T (pt)
PL (2)	PL3574901T3 (pt)
PT (2)	PT3027186T (pt)
RS (1)	RS59108B1 (pt)
RU (1)	RU2670617C2 (pt)
SI (1)	SI3027186T1 (pt)
WO (1)	WO2015015407A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9421198B2 (en)	2013-07-30	2016-08-23	Teoxane	Composition comprising hyaluronic acid and mepivacaine
FR3015290B1 (fr) *	2013-12-23	2017-01-13	Lab Vivacy	Compositions d'acide hyaluronique compreant de la mepivacaine
US10004824B2 (en)	2015-05-11	2018-06-26	Laboratoires Vivacy	Compositions comprising at least one polyol and at least one anesthetic
FR3036035B1 (fr)	2015-05-11	2018-10-05	Laboratoires Vivacy	Compositions comprenant au moins un polyol et au moins un anesthesique
EP3165233B1 (en) *	2015-08-28	2021-08-18	Latvijas Universitate	Biomaterial for treatment of acute and chronic skin wounds
FR3058064B1 (fr) *	2016-10-28	2020-08-07	Lab Vivacy	Composition a base d'acide hyaluronique comprenant de la mepivacaine
EP3354258A1 (en) *	2017-01-31	2018-08-01	Teoxane SA	Use of a cohesive gel as a matrix material in a periodontal pocket
TWI716671B (zh) *	2017-02-28	2021-01-21	南韓商Ｃｇ生物技術有限公司	皮膚注射用組成物
MX2019012272A (es) *	2017-04-12	2020-07-28	Urigen Pharmaceuticals Inc	Artículo de fabricación que comprende anestésico local, regulador de ph y glicosaminoglicano en jeringa con estabilidad mejorada.
KR102091452B1 (ko) *	2017-12-19	2020-03-20	대화제약 주식회사	국소 마취제 및 히알루론산 하이드로겔을 포함하는 사전충전형 주사기의 제조방법
WO2019130360A1 (en) *	2017-12-29	2019-07-04	Matex Lab S.P.A.	Method to prepare filler with a hyaluronic acid base comprising a neutralization step
AU2019218711A1 (en)	2018-02-06	2020-08-20	Regen Lab Sa	Cross-linked hyaluronic acids and combinations with PRP/BMC
CN110721142A (zh) *	2018-07-17	2020-01-24	上海美白臻生物科技有限公司	一种全效型微整专用玻尿酸制备工艺
WO2020130684A1 (ko) *	2018-12-20	2020-06-25	주식회사 엘지화학	우수한 필러 특성을 갖는 히알루론산 하이드로겔을 포함하는 필러
EP3861996A1 (en)	2020-02-04	2021-08-11	I+Med S. Coop.	Controlled release system of phytocannabinoids formulations soluble in aqueous media, methods and uses thereof
TWI731660B (zh) *	2020-04-24	2021-06-21	透策生技股份有限公司	利用加壓手段以加速注射式填充物分散的處理方法
CN113896915B (zh) *	2021-11-10	2024-02-13	爱美客技术发展股份有限公司	一种凝胶材料及其制备方法与应用
WO2023158281A1 (ko) *	2022-02-21	2023-08-24	이광미	금속 티오옥토일 히알루로네이트 복합체 및 그의 용도
KR102451308B1 (ko) *	2022-02-21	2022-10-07	이광미	금속 티오옥토일 히알루로네이트 복합체 및 이의 제조 방법
KR102559788B1 (ko) *	2022-04-21	2023-07-27	주식회사 티앤알바이오팹	다단계 탈세포화된 조직 매트릭스 및 이의 제조방법
CN115737506B (zh) *	2022-12-16	2023-09-05	江苏亨瑞生物医药科技有限公司	一种含有胶原蛋白的面膜及其制备方法
KR102680817B1 (ko) *	2023-06-02	2024-07-03	주식회사 에스씨엘	히알루론산 필러의 제조방법

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2799679A (en)	1955-04-28	1957-07-16	Bofors Ab	Process of preparing amides of heterocyclic carboxylic acids
GB826668A (en)	1955-06-27	1960-01-20	Crookes Lab Ltd	Process for manufacturing basic carboxamides
IT1303735B1 (it)	1998-11-11	2001-02-23	Falorni Italia Farmaceutici S	Acidi ialuronici reticolati e loro usi medici.
DE10246340A1 (de)	2002-10-04	2004-04-29	Wohlrab, David, Dr.	Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung
US8124120B2 (en)	2003-12-22	2012-02-28	Anika Therapeutics, Inc.	Crosslinked hyaluronic acid compositions for tissue augmentation
US20050142152A1 (en)	2003-12-30	2005-06-30	Leshchiner Adelya K.	Polymeric materials, their preparation and use
CA2554190A1 (en)	2004-01-23	2005-08-04	Ohio University	Pgg separation and purification
JP4875988B2 (ja) *	2004-11-15	2012-02-15	株式会社資生堂	架橋ヒアルロン酸ゲルの製造方法
KR101324870B1 (ko)	2005-12-06	2013-11-01	엔테그리스, 아이엔씨.	다공성 패드를 위한 성형된 회전가능 기부
JP2011521744A (ja)	2008-05-30	2011-07-28	アラーガン、インコーポレイテッド	軟質組織増強充填剤、生物活性剤および液状又はゲル状の他の生体適合材料を注入するための注入装置
US8450475B2 (en)	2008-08-04	2013-05-28	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
FR2945293B1 (fr)	2009-05-11	2011-06-17	Teoxane	Procede de preparation d'un gel reticule.
RU2530604C2 (ru) *	2009-05-29	2014-10-10	Галдерма Ресерч Энд Девелопмент	Инъецируемая комбинация агонистов адренергических рецепторов с наполнителями для уменьшения кожных реакций на инъекцию
US20110171310A1 (en)	2010-01-13	2011-07-14	Allergan Industrie, Sas	Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110171286A1 (en)	2010-01-13	2011-07-14	Allergan, Inc.	Hyaluronic acid compositions for dermatological use
FR2962040B3 (fr)	2010-07-05	2012-08-10	Alain Villette	Composition injectable comprenant un medicament injectable et un gel
PT2637710T (pt)	2010-11-08	2017-07-12	Allergan Ind Sas	Formulações à base de ácido hialurónico
EP2484387A1 (en)	2011-02-03	2012-08-08	Q-Med AB	Hyaluronic acid composition
US9241921B2 (en) *	2011-05-02	2016-01-26	Pankaj Modi	Photosensitizer composition for treating skin disorders
EP2714002B1 (en) *	2011-06-03	2019-04-03	Allergan, Inc.	Dermal filler compositions including antioxidants
FR2979539B1 (fr)	2011-09-05	2013-09-27	Teoxane	Composition sterile dermo-injectable
US20130131632A1 (en)	2011-11-18	2013-05-23	Allergan, Inc.	Injection device and method for diluting an injectable fluid
ES2686114T3 (es)	2011-12-20	2018-10-16	Angioclinic Ag	El ácido hialurónico y su uso para el tratamiento de la insuficiencia venosa y las venas varicosas
FR2991876B1 (fr)	2012-06-13	2014-11-21	Vivacy Lab	Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
CN102805882B (zh) *	2012-08-28	2014-04-23	华熙福瑞达生物医药有限公司	一种软组织填充剂在使用前与麻醉剂注射液混合的方法
FR2994846B1 (fr)	2012-08-29	2014-12-26	Vivacy Lab	Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium
US9801807B2 (en) *	2012-12-13	2017-10-31	Shamroc, Inc.	Topical formulations for increasing the dermal concentration of hyaluronic acid
WO2014165113A1 (en)	2013-03-12	2014-10-09	Allergan Holdings France S.A.S.	Cross-linked hyaluronic acid threads for treatment of striae
US9421198B2 (en)	2013-07-30	2016-08-23	Teoxane	Composition comprising hyaluronic acid and mepivacaine
FR3015290B1 (fr)	2013-12-23	2017-01-13	Lab Vivacy	Compositions d'acide hyaluronique compreant de la mepivacaine

2013
- 2013-07-30 US US13/954,360 patent/US9421198B2/en active Active
2014
- 2014-07-29 HU HUE14767131A patent/HUE045969T2/hu unknown
- 2014-07-29 LT LTEP14767131.7T patent/LT3027186T/lt unknown
- 2014-07-29 KR KR1020217027606A patent/KR20210110406A/ko not_active Application Discontinuation
- 2014-07-29 CN CN201480054186.7A patent/CN105682657A/zh active Pending
- 2014-07-29 RU RU2016106152A patent/RU2670617C2/ru active
- 2014-07-29 KR KR1020167005500A patent/KR20160038047A/ko not_active IP Right Cessation
- 2014-07-29 PT PT14767131T patent/PT3027186T/pt unknown
- 2014-07-29 ES ES14767131T patent/ES2743755T3/es active Active
- 2014-07-29 BR BR112016002171A patent/BR112016002171A2/pt not_active Application Discontinuation
- 2014-07-29 PT PT191802982T patent/PT3574901T/pt unknown
- 2014-07-29 CA CA2919792A patent/CA2919792C/en active Active
- 2014-07-29 JP JP2016530646A patent/JP6543625B2/ja active Active
- 2014-07-29 CN CN202110975571.7A patent/CN113648459A/zh active Pending
- 2014-07-29 EP EP19180298.2A patent/EP3574901B1/en active Active
- 2014-07-29 DK DK19180298.2T patent/DK3574901T3/da active
- 2014-07-29 ES ES19180298T patent/ES2910519T3/es active Active
- 2014-07-29 AU AU2014298046A patent/AU2014298046B2/en active Active
- 2014-07-29 PL PL19180298T patent/PL3574901T3/pl unknown
- 2014-07-29 RS RS20191039A patent/RS59108B1/sr unknown
- 2014-07-29 EP EP14767131.7A patent/EP3027186B1/en not_active Revoked
- 2014-07-29 WO PCT/IB2014/063503 patent/WO2015015407A1/en active Application Filing
- 2014-07-29 SI SI201431293T patent/SI3027186T1/sl unknown
- 2014-07-29 DK DK14767131.7T patent/DK3027186T3/da active
- 2014-07-29 PL PL14767131T patent/PL3027186T3/pl unknown
2016
- 2016-02-16 US US15/044,236 patent/US9789226B2/en active Active
- 2016-07-20 US US15/214,983 patent/US9498562B1/en active Active
2017
- 2017-09-15 US US15/705,809 patent/US9925309B2/en active Active
2018
- 2018-02-13 US US15/895,220 patent/US10322212B2/en active Active
- 2018-07-17 US US16/037,402 patent/US10786601B2/en active Active
2019
- 2019-02-22 US US16/282,598 patent/US10413637B2/en active Active
- 2019-07-25 HR HRP20191345 patent/HRP20191345T1/hr unknown
- 2019-09-18 CY CY20191100978T patent/CY1122648T1/el unknown
2020
- 2020-08-26 US US17/003,377 patent/US11406738B2/en active Active
2022
- 2022-07-12 US US17/862,711 patent/US20220362439A1/en active Pending

Also Published As

Publication number	Publication date
CA2919792C (en)	2020-01-28
US9925309B2 (en)	2018-03-27
PL3027186T3 (pl)	2019-12-31
JP2016527264A (ja)	2016-09-08
AU2014298046A1 (en)	2016-03-10
JP6543625B2 (ja)	2019-07-10
EP3574901B1 (en)	2022-01-26
CY1122648T1 (el)	2021-05-05
AU2014298046B2 (en)	2018-11-08
DK3027186T3 (da)	2019-09-16
US10413637B2 (en)	2019-09-17
RU2670617C2 (ru)	2018-10-24
EP3027186A1 (en)	2016-06-08
ES2743755T3 (es)	2020-02-20
US20180169304A1 (en)	2018-06-21
KR20160038047A (ko)	2016-04-06
BR112016002171A2 (pt)	2017-08-01
CN113648459A (zh)	2021-11-16
US20220362439A1 (en)	2022-11-17
US10786601B2 (en)	2020-09-29
WO2015015407A1 (en)	2015-02-05
SI3027186T1 (sl)	2019-09-30
US20160325021A1 (en)	2016-11-10
US20190184065A1 (en)	2019-06-20
US20180318469A1 (en)	2018-11-08
LT3027186T (lt)	2019-09-10
KR20210110406A (ko)	2021-09-07
PL3574901T3 (pl)	2022-05-09
US9421198B2 (en)	2016-08-23
US20180021480A1 (en)	2018-01-25
US10322212B2 (en)	2019-06-18
US20150038457A1 (en)	2015-02-05
DK3574901T3 (da)	2022-03-07
RS59108B1 (sr)	2019-09-30
US20160166554A1 (en)	2016-06-16
HRP20191345T1 (hr)	2019-11-01
CA2919792A1 (en)	2015-02-05
US20200390940A1 (en)	2020-12-17
ES2910519T3 (es)	2022-05-12
EP3027186B1 (en)	2019-06-19
RU2016106152A (ru)	2017-08-31
EP3574901A1 (en)	2019-12-04
US9789226B2 (en)	2017-10-17
US9498562B1 (en)	2016-11-22
US11406738B2 (en)	2022-08-09
CN105682657A (zh)	2016-06-15
HUE045969T2 (hu)	2020-01-28
PT3027186T (pt)	2019-09-09

Publication	Publication Date	Title
PL3574901T3 (pl)	2022-05-09	Urządzenia do iniekcji zawierające kompozycję kwasu hialuronowego i chlorowodorku mepiwakainy
HRP20180953T1 (hr)	2018-07-27	Supstituirani 3-haloalilaminski inhibitori za ssao i njihove uporabe
HK1223913A1 (zh)	2017-08-11	經取代的苯甲酰胺及其使用方法
HK1217410A1 (zh)	2017-01-13	抑制劑及其用途
HK1209736A1 (en)	2016-04-08	N-substituted benzamides and methods of use thereof n-
SG11201507358VA (en)	2015-10-29	Pharmaceutical composition of s-ketamine hydrochloride
SG10201802104QA (en)	2018-05-30	Pharmaceutical composition of s-ketamine hydrochloride
IL274454A (en)	2020-06-30	Hyaluronic acid preparations including mepivacaine
EP2961386A4 (en)	2016-11-02	MIARN PROFILING COMPOSITIONS AND METHODS OF USE
PT3050877T (pt)	2020-01-14	Derivado de amina cíclica e sua utilização farmacêutica
HK1222560A1 (zh)	2017-07-07	抗流感組合物和方法
EP2858642A4 (en)	2015-12-02	NOVEL IMINO SUGAR AND ITS APPLICATIONS
IL239872A0 (en)	2015-08-31	Metriptase inhibitors and pharmaceutical preparations containing them
GB201206336D0 (en)	2012-05-23	Avoidance of harmonic injection